This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sientra, a Goleta-based breast implant manufacturer, submitted documents to the Securities and Exchange Commission to offer an additional $75 million worth of stock on Sept. 3. Sientra raised about $77 million after paying underwriting expenses when it started trading on the Nasdaq on Oct. 29, 2014. At the time, the company said it sold 5.75 Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
By Staff Report / Thursday, August 20th, 2015 / Latest news, Technology / Comments Off on Survey to assess Internet needs in Tri-Counties
The San Luis Obispo Economic Vitality Corp. and the Broadband Consortium of the Pacific Coast are releasing a survey to better understand the Internet needs of businesses, homes and schools in the region. The survey will include field speed tests to confirm local broadband speed and service needs. The survey also asks businesses about their Read More →
Camarillo-based Semtech said it lost $313,000 in an earnings report for the second quarter of its 2016 fiscal year on Aug. 19. Semtech makes analog and mixed signal semiconductors. The results continue a slow year for Semtech, which lost $142,000 in the first quarter. That amounted to a loss of less than one cent per Read More →
Thousand Oaks-based Amgen agreed to pay $71 million in a settlement with California, 47 other states and the District of Columbia because the biotech giant unlawfully promoted two drugs. According to a news release Aug. 18 from California Attorney General Kamala Harris, Amgen unlawfully promoted biologic medications Enbrel and Aranesp by “promoting Aranesp for dosing Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.